Atwater Malick’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-81,303
| Closed | -$6.48M | – | 78 |
|
|
2024
Q1 | $6.48M | Sell |
81,303
-1,882
| -2% | -$150K | 2.29% | 20 |
|
|
2023
Q4 | $6.57M | Buy |
83,185
+1,678
| +2% | +$132K | 2.57% | 17 |
|
|
2023
Q3 | $5.69M | Buy |
81,507
+1,065
| +1% | +$74.4K | 2.5% | 18 |
|
|
2023
Q2 | $5.56M | Buy |
80,442
+4,423
| +6% | +$306K | 2.38% | 20 |
|
|
2023
Q1 | $5.65M | Buy |
76,019
+3,500
| +5% | +$260K | 2.65% | 20 |
|
|
2022
Q4 | $6.76M | Buy |
72,519
+1,603
| +2% | +$149K | 3.33% | 18 |
|
|
2022
Q3 | $6.76M | Buy |
70,916
+1,153
| +2% | +$110K | 3.78% | 11 |
|
|
2022
Q2 | $6.46M | Buy |
69,763
+1,732
| +3% | +$160K | 3.4% | 15 |
|
|
2022
Q1 | $6.89M | Buy |
68,031
+1,758
| +3% | +$178K | 3.32% | 15 |
|
|
2021
Q4 | $6.84M | Buy |
66,273
+1,194
| +2% | +$123K | 3.17% | 17 |
|
|
2021
Q3 | $5.52M | Buy |
65,079
+2,205
| +4% | +$187K | 2.92% | 20 |
|
|
2021
Q2 | $5.25M | Buy |
62,874
+3,121
| +5% | +$260K | 2.9% | 20 |
|
|
2021
Q1 | $4.5M | Sell |
59,753
-2,757
| -4% | -$207K | 2.76% | 20 |
|
|
2020
Q4 | $4.27M | Buy |
62,510
+1,434
| +2% | +$97.9K | 2.68% | 22 |
|
|
2020
Q3 | $3.57M | Buy |
61,076
+1,917
| +3% | +$112K | 2.5% | 22 |
|
|
2020
Q2 | $3.84M | Buy |
59,159
+1,936
| +3% | +$126K | 3.03% | 20 |
|
|
2020
Q1 | $3.4M | Buy |
57,223
+4,298
| +8% | +$255K | 3.26% | 19 |
|
|
2019
Q4 | $3.93M | Buy |
52,925
+1,259
| +2% | +$93.5K | 3.13% | 21 |
|
|
2019
Q3 | $3.26M | Buy |
51,666
+4,415
| +9% | +$278K | 2.74% | 23 |
|
|
2019
Q2 | $2.58M | Buy |
47,251
+3,668
| +8% | +$200K | 2.36% | 24 |
|
|
2019
Q1 | $2.35M | Buy |
43,583
+4,943
| +13% | +$267K | 2.3% | 24 |
|
|
2018
Q4 | $2.53M | Buy |
+38,640
| New | +$2.53M | 2.83% | 22 |
|